Basel, 5 November 2021 - With respect to the decision 795/01 of the Swiss Takeover Board of 4 November 2021 regarding the request of André Hoffmann, Marie-Anne Hoffmann, Vera Michalski, Alexander Hoffmann, Frederic Hoffmann, Isabel Hoffmann, Lucas Hoffmann, Marina Hoffmann, Kasia BarbotinLarrieu, Tatiana Fabre, Andreas Oeri, Catherine Oeri, Sabine Duschmalé, Jörg Duschmalé, Lukas Duschmalé and Stiftung Wolf for determination that no duty to make an offer exists, subsidiarily that an exemption from the duty to make an offer be granted with respect to Roche Holding Ltd (available at www.takeover.ch), Roche Holding Ltd publishes the following:
Decision of the Swiss Takeover Board
"The Swiss Takeover Board decrees:
Objection pursuant to Art. 58 TOO
A shareholder who can prove that he, she or it holds at least three per cent of the voting rights of Roche Holding Ltd, whether exercisable or not (qualified shareholder, Art. 56 para. 3 TOO), and who has not previously participated in the proceedings, may object to the decision of the Swiss Takeover Board. The objection must be filed with the Swiss Takeover Board within five trading days of the publication of the decision. It must contain a request and a summary statement of grounds as well as proof of the participation pursuant to art. 56 para. 3 and 4 TOO (art. 58 para. 3 TOO).
* English translation of the original German text.
Media Requests
Phone: +41 61 688 8888 / e-mail: media.relations@roche.com
Barbara Schädler Phone: +41 61 687 14 27 |
Dr. Nicolas Dunant Phone: +41 79 264 39 25 |
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
get the latest news and updates to your inbox.